In summary, by examining the protein expression, we hypothesized that high expression of NT5DC2 is a negative prognostic marker in the ADC subgroup of NSCLC patients and confirmed our hypothesis via gene expression analysis using the tool of kmplot.com (accessed on 3 March 2022). The gene discussed is NT5DC2; the disease is non-small cell lung carcinoma.